ASTION PHARMA A/S: Financial statements 2023
CVR: 34224781
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
ASTION PHARMA A/S (CVR 34224781) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 132,462 and a net result of DKK 10,935 compared with DKK 25,126 the year before. That is a decrease of 35.7% compared with the year before. Equity in the 2023 report amounted to DKK -5,539,445.
- Gross Profit
- DKK 132,462
- Profit/Loss
- DKK 10,935
- Equity
- DKK -5,539,445
- Total Assets
- DKK 2,965,699
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 132K | 11K | -5.5M | - |
| 2022 | - | 206K | 25K | -5.6M | - |
| 2021 | - | -1.4M | -6.3M | -5.6M | - |
| 2020 | - | -3.6M | -4.8M | 697K | - |
| 2019 | - | -1.8M | -1.8M | - | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
ASTION PHARMA A/S has published its annual report for 2022. Gross profit came to DKK 206,156, and the net result was DKK 25,126.
About ASTION PHARMA A/S
ASTION PHARMA A/S is a Danish company of the type Aktieselskab based in Vissenbjerg, founded in 2012. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named AP NEWCO A/S. The management consists of Torben Rønje. The board consists of Ib Henrik Rønje (chair), Henrik Grønfeldt-Sørensen and Torben Rønje. The company is owned by KAPITALFORMIDLINGS INSTITUTTET A/S. The company has 0 employees (2017). In 2025, the company reported a gross profit of DKK -18,071 and a net result of DKK -164,736 compared with DKK -246,248 the year before. Equity in the 2025 report amounted to DKK -5,950,429.